Search

Your search keyword '"Gritsch, Herbert"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Gritsch, Herbert" Remove constraint Author: "Gritsch, Herbert" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
45 results on '"Gritsch, Herbert"'

Search Results

1. In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

2. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease

6. Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease

7. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease

10. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

16. Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys

18. The role of ultralarge multimers in recombinant human von Willebrand factor – a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease

19. Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

20. Pharmacokinetics of BAX 826, a Polysialylated Full-Length rFVIII, in Hemophilia a Mice, Rats, and Cynomolgus Monkeys

26. Pharmacokinetics of Baxter’s Longer Acting rFVIII (BAX 855) in Factor VIII Ko Mice, Rats and Cynomolgus Monkeys

35. Biochemical and Functional Characterization of PEGylated rVWF.

38. Mutation of the surface-exposed amino acid Trp2313to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein

40. In Vivo Characterization of Recombinant von Willebrand Factor in Dogs With von Willebrand Disease

42. Mutation of the surface-exposed amino acid Trp2313 to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein.

43. SHORT REPORT Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model.

45. An Automated pre-Dilution Setup for Von Willebrand Factor Activity Assays.

Catalog

Books, media, physical & digital resources